Health Care [ 9/12 ] | Biotechnology [ 43/75 ]
NASDAQ | Common Stock
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults.
LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021.
The company was founded in 2013 and is headquartered in Solana Beach, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 31, 25 | -1.16 Decreased by -152.17% | -0.92 Decreased by -25.54% |
| Nov 5, 25 | -0.59 Decreased by -55.26% | -0.40 Decreased by -47.50% |
| Jul 30, 25 | -0.53 Decreased by -32.50% | -0.61 Increased by +13.11% |
| May 7, 25 | -0.53 Increased by +84.99% | -0.47 Decreased by -12.77% |
| Mar 19, 25 | -0.46 Decreased by -15.00% | -0.10 Decreased by -360.00% |
| Nov 6, 24 | -0.38 Decreased by -58.33% | -0.43 Increased by +11.34% |
| Aug 15, 24 | -0.40 Increased by +94.11% | -0.67 Increased by +40.30% |
| May 8, 24 | -3.53 Decreased by -17.28% | -0.84 Decreased by -320.24% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 1.59 M Increased by +2.31 K% | -35.90 M Decreased by -183.72% | Decreased by -2.26 K% Increased by +88.21% |
| Sep 30, 25 | 12.50 M Increased by +N/A% | -16.70 M Decreased by -63.49% | Decreased by -133.60% Decreased by N/A% |
| Jun 30, 25 | 5.00 M Increased by +N/A% | -14.91 M Decreased by -45.43% | Decreased by -298.24% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -14.62 M Increased by +12.19% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 66.00 K Increased by +N/A% | -12.65 M Increased by +46.60% | Decreased by -19.17 K% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -10.21 M Increased by +45.90% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -10.25 M Increased by +30.37% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -16.65 M Decreased by -31.40% | Decreased by N/A% Decreased by N/A% |